-+ 0.00%
-+ 0.00%
-+ 0.00%

ARROWHEAD PHARMACEUTICALS SHARES UP 18.1% PREMARKET AFTER BLOOD-FAT DRUG MEETS LATE-STAGE TRIAL GOALS

Reuters·07/22/2026 12:51:13

Please log in to view news